Physician profile
Daniel M Ward
NPI 1922065820
$345,851.91
in general payments reported to CMS, 2019-2025
20 companies · $59K in 2025
The $59K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81K · 2020: $57K · 2021: $44K · 2022: $65K · 2023: $18K · 2024: $21K · 2025: $59K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $74K · Travel and Lodging: $18K · Food and Beverage: $6,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $74,250.00 |
| Travel and Lodging | $18,250.86 |
| Food and Beverage | $6,147.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $338,556.48 | 2019-2025 | Mako, Triathlon, Insignia |
| Epi Health, LLC | $6,000.00 | 2020 | |
| Exactech, INC. | $230.65 | 2025 | |
| Pacira Therapeutics, INC. | $171.85 | 2019-2020 | |
| Heron Therapeutics, INC. | $166.89 | 2021-2023 | Zynrelef |
| Depuy Synthes Sales INC. | $106.32 | 2020-2024 | Monovisc, Orthovisc |
| Smith+Nephew, INC. | $91.44 | 2023 | Real Intelligence |
| Kci USA, INC. | $86.84 | 2020 | |
| Bioventus LLC | $83.62 | 2019-2023 | Durolane |
| Zimmer Biomet Holdings, INC. | $58.14 | 2025 | G7 |
| Convatec INC. | $44.32 | 2019 | |
| Fidia Pharma USA INC. | $41.87 | 2024-2025 | Hymovis, Triluron, Hyalgan |
| Ferring Pharmaceuticals INC. | $39.79 | 2020-2021 | |
| Heraeus Medical, LLC. | $37.56 | 2020-2021 | |
| Encore Medical, LP | $26.20 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $24.91 | 2019 | |
| Ethicon US, LLC | $24.57 | 2019 | |
| Baudax Bio INC. | $20.51 | 2021 | |
| Medical Device Business Services, INC. | $20.36 | 2023 | Attune |
| Redhill Biopharma INC. | $19.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.